^SAMPLE = GSM795963!Sample_title = Sample 37P_ependymoma-250ksty!Sample_geo_accession = GSM795963!Sample_status = Public on Feb 09 2012!Sample_submission_date = Sep 13 2011!Sample_last_update_date = Feb 09 2012!Sample_type = genomic!Sample_channel_count = 1!Sample_source_name_ch1 = primary ependymoma DNA sample from patient 37!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = patient: 37!Sample_characteristics_ch1 = disease state: ependymoma!Sample_characteristics_ch1 = ependymoma status: primary!Sample_characteristics_ch1 = gender: female!Sample_characteristics_ch1 = location: supratentorial (ST)!Sample_characteristics_ch1 = age: 13.8yrs!Sample_characteristics_ch1 = tumour grade: World Health Organisation Grade II!Sample_characteristics_ch1 = patient outcome: Alive and no disease progression!Sample_characteristics_ch1 = tumour 1q gain status: No 1q gain!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted snap frozen tumour tissue and mononuclear cell preparations  from peripheral blood, using a standard phenol/chloroform/isoamyl alcohol method. DNA quality and quantity was assessed using a Nandrop spectrophotometer and agarose gel electrophoresis.!Sample_label_ch1 = Biotin!Sample_label_protocol_ch1 = As per manufacturer (Affymetrix)!Sample_hyb_protocol = DNA was restriction digested, PCR amplified, fragmented, labelled and hybridised to each array according to the manufacturer's instructions.!Sample_scan_protocol = The Arrays were then washed using Affymetrix fluidics stations, and scanned using the Gene Chip Scanner 3000.!Sample_description = primary ependymoma, female, ST, 13.8yrs!Sample_description = S0398FL0017 sty!Sample_description = Hybridized to 250K_Sty!Sample_data_processing = CEL files and CHP files (generated by Affymetrix GTYPE using the BRLMM algorithm) were processed by CNAG. Normalization was performed using the constitutional samples. Data processing was performed as described in Miller et al Neuro Oncol 2011;13(8):866-79.!Sample_data_processing = Primary data description: Genotype Call (SNP call): AA, AB, BB, NC, and NoCall;!Sample_platform_id = GPL3720!Sample_contact_name = John-Paul,,Kilday!Sample_contact_email = mgzjk@exmail.nottingham.ac.uk!Sample_contact_phone = 0115 8230718!Sample_contact_laboratory = D18!Sample_contact_department = CBTRC!Sample_contact_institute = University of Nottingham !Sample_contact_address = Derby Road!Sample_contact_city = Nottingham!Sample_contact_zip/postal_code = NG7 2UH!Sample_contact_country = United Kingdom!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795963/suppl/GSM795963_S0398FL0017-250ksty.CEL.gz!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795963/suppl/GSM795963_S0398FL0017-250ksty.brlmm.chp.gz!Sample_series_id = GSE32101!Sample_data_row_count = 238354#ID_REF = PROBE SET NAME#VALUE = CALL#CONFIDENCE = #FORCED CALL = #CONTRAST = #STRENGTH = !sample_table_beginID_REF	VALUE	CONFIDENCE	FORCED CALL	CONTRAST	STRENGTHAFFX-2315060	AB	0.003777	AB	-0.098454	12.255900AFFX-2315061	BB	0.010644	BB	-0.767120	10.784787AFFX-2315062	AA	0.001561	AA	0.648640	10.174685AFFX-2315057	AB	0.002957	AB	-0.054855	10.356755AFFX-2315058	AA	0.035926	AA	0.749351	12.052902AFFX-2315059	AA	0.000500	AA	0.830814	10.835986AFFX-2315063	AA	0.000002	AA	0.820923	10.637963AFFX-2315064	AB	0.061176	AB	0.093483	9.440602AFFX-2315065	BB	0.012216	BB	-0.611315	10.224742AFFX-2315066	AB	0.005617	AB	-0.165160	10.258007AFFX-2315067	AB	0.027275	AB	0.133659	11.364471AFFX-2315068	AA	0.001736	AA	0.807445	10.412312AFFX-2315069	AB	0.015009	AB	-0.237719	9.593648AFFX-2315070	AB	0.014990	AB	-0.086223	10.136926AFFX-2315071	BB	0.017150	BB	-0.819325	10.488860AFFX-2315072	AA	0.003051	AA	0.737068	11.025792AFFX-2315073	AA	0.009926	AA	0.801210	10.794148AFFX-2315074	AB	0.043142	AB	-0.162116	9.383994AFFX-2315075	AA	0.032643	AA	0.678551	11.257454AFFX-2315076	BB	0.009837	BB	-0.728454	11.003788!sample_table_end